From Lewis Acid to Lewis Base by La3+-to-Y3+ Substitution in α-YB5O9: Local Structure Modification Induced Lewis Basicity.

Different from the common perspective of average structure, we propose that the locally elongated metal-oxygen bonds induced by La3+-to-Y3+ substitution to a Lewis acid α-YB5O9 generate medium-strength basic sites. Experimentally, NH3- and CO2-TPD experiments prove that the La3+ doping of α-Y1-xLaxB5O9 (0 ≤ x ≤ 0.24) results in the emergence of new medium-strength basic sites and the increasing La3+ concentration modifies the number, not the strength, of the acidic and basic sites. The catalytic IPA conversion exhibits a reversal of the product selectivity, i.e., from 93% of propylene for α-YB5O9 to ∼90% of acetone for α-Y0.76La0.24B5O9, which means the La3+ doping gradually turns the solid from a Lewis acid to a Lewis base. Besides, α-Y0.76RE0.24B5O9 (RE = Ce, Eu, Gd, Tm) compounds were prepared to consolidate the above conjecture, where the acetone selectivity exhibits a linear dependence on the ionic radius (or electronegativity). This work suggests that the substitution-induced local structure change deserves more attention.

Development of a Rare Earth Nanoprobe Enables In Vivo Real-Time Detection of Sentinel Lymph Node Metastasis of Breast Cancer Using NIR-IIb Imaging.

Sentinel lymph node (SLN) biopsy plays a critical role in axillary staging of breast cancer. However, traditional SLN mapping does not accurately discern the presence or absence of metastatic disease. Detection of SLN metastasis largely hinges on examination of frozen sections or paraffin-embedded tissues post-SLN biopsy. To improve detection of SLN metastasis, we developed a second near-infrared (NIR-II) in vivo fluorescence imaging system, pairing erbium-based rare-earth nanoparticles (ErNP) with bright down-conversion fluorescence at 1,556 nm. To visualize SLNs bearing breast cancer, ErNPs were modified by balixafortide (ErNPs@POL6326), a peptide antagonist of the chemokine receptor CXCR4. The ErNPs@POL6326 probes readily drained into SLNs when delivered subcutaneously, entering metastatic breast tumor cells specifically via CXCR4-mediated endocytosis. NIR fluorescence signals increased significantly in tumor-positive versus tumor-negative SLNs, enabling accurate determination of SLN breast cancer metastasis. In a syngeneic mouse mammary tumor model and a human breast cancer xenograft model, sensitivity for SLN metastasis detection was 92.86% and 93.33%, respectively, and specificity was 96.15% and 96.08%, respectively. Of note, the probes accurately detected both macrometastases and micrometastases in SLNs. These results overall underscore the potential of ErNPs@POL6326 for real-time visualization of SLNs and in vivo screening for SLN metastasis. SIGNIFICANCE: NIR-IIb imaging of a rare-earth nanoprobe that is specifically taken up by breast cancer cells can accurately detect breast cancer macrometastases and micrometastases in sentinel lymph nodes.

A Lewis acid-base paired InBO3 catalyst: synthesis and high selectivity for isopropanol dehydrogenation.

Whilst metal borates are well known as optical materials, their potential in solid catalysis has been less investigated. The calcite structured InBO3 was selected as the target borate and was prepared using a solvothermal method. High-resolution transmission electron microscopy and powder X-ray diffraction prove that the material has a nanoparticle morphology with an average size ∼50 nm and high crystallinity. Intrinsic surface oxygen vacancies, which are beneficial to catalysis, were detected using X-ray photoelectron spectroscopy. Lewis acidity and basicity were both observed using NH3-/CO2-temperature-programmed desorption experiments, and the total acid and base amounts were found to be 46.6 and 123.8 µmol g-1, respectively. Catalytic dehydration and dehydrogenation reactions for isopropanol at elevated temperatures were conducted in a fixed bed reactor to evaluate the catalytic performance of InBO3. InBO3 exhibits a high conversion rate (>90.5%) and, most importantly, a high dehydrogenation selectivity (acetone selectivity >92.5%), whilst the optimal acetone yield achieved was 121.3 mmol h-1 g-1cat at 350 °C. This study on InBO3 strongly suggests that metal borates have promising applications in heterogeneous catalysis.

Co2+ to Al3+ Substitution Induced Dual-Site Synergistic Catalysis to Friedel-Crafts Alkylation Reactions.

The dual-site synergistic effect in heterogeneous catalysis is quite interesting, and also complex because at least two substrate molecules are adsorbed or activated on the catalyst surface, which apparently needs two spatially separated and functionally independent active sites. It would become more difficult when the substrate molecules are large ones. The replacement of Al3+ in Al4 B6 O15 lattice with Co2+ leads to the formation of unsaturated Co2+ (4-fold coordination) along with oxygen vacancies (Ov ). The former one behaves as a medium-strength Lewis acid site, and can adsorb and activate molecules with a nitro group (e. g., ß-nitrostyrene). The latter one can adsorb and activate oxygen species, which further activates the indole derivatives. Next, the spatially separated dual sites on the catalyst surface can synergistically and efficiently catalyze their Friedel-Crafts alkylation reactions under mild conditions. The high durability can be proved by the as-maintained high yields, that is, 98, 93, 96, 92 and 90 % for 5 runs, respectively. The reaction kinetics obey the second-order characteristic. Annealing under hydrogen condition can further generate more surficial Ov , leading to an improvement to the catalytic activity. A simple and probably routine aliovalent doping endows such a complex synergistic catalysis involving two large substrate molecules, providing an inspired perspective of developing dual-site catalysts.

Novel Self-Assembled Multifunctional Nanoprobes for Second-Near-Infrared-Fluorescence-Image-Guided Breast Cancer Surgery and Enhanced Radiotherapy Efficacy.

Breast-conserving surgery (BCS) is the predominant treatment approach for initial breast cancer. However, due to a lack of effective methods evaluating BCS margins, local recurrence caused by positive margins remains an issue. Accordingly, radiation therapy (RT) is a common modality in patients with advanced breast cancer. However, while RT also protects normal tissue and enhances tumor bed doses to improve therapeutic effects, current radiosensitizers cannot meet these urgent clinical needs. To address this, a novel self-assembled multifunctional nanoprobe (NP) gadolinium (Gd)-diethylenetriaminepentaacetic acid-human serum albumin (HSA)@indocyanine green-Bevacizumab (NPs-Bev) is synthesized to improve the efficacy of fluorescence-image-guided BCS and RT. Fluorescence image guidance of the second near infrared NP improves complete resection in tumor-bearing mice and accurately discriminates between benign and malignant mammary tissue in transgenic mice. Moreover, targeting tumors with NPs induces more reactive oxygen species under X-ray radiation therapy, which not only increases RT sensitivity, but also reduces tumor progression in mice. Interestingly, self-assembled NPs-Bev using HSA, the magnetic resonance contrast agent and Bevacizumab-targeting vascular growth factor A, which are clinically safe reagents, are safe in vitro and in vivo. Therefore, the novel self-assembled NPs provide a solid precision therapy platform to treat breast cancer.

Biomarker Genes Discovery of Alzheimer's Disease by Multi-Omics-Based Gene Regulatory Network Construction of Microglia.

Microglia, the major immune cells in the brain, mediate neuroinflammation, increased oxidative stress, and impaired neurotransmission in Alzheimer's disease (AD), in which most AD risk genes are highly expressed. In microglia, due to the limitations of current single-omics data analysis, risk genes, the regulatory mechanisms, the mechanisms of action of immune responses and the exploration of drug targets for AD immunotherapy are still unclear. Therefore, we proposed a method to integrate multi-omics data based on the construction of gene regulatory networks (GRN), by combining weighted gene co-expression network analysis (WGCNA) with single-cell regulatory network inference and clustering (SCENIC). This enables snRNA-seq data and bulkRNA-seq data to obtain data on the deeper intermolecular regulatory relationships, related genes, and the molecular mechanisms of immune-cell action. In our approach, not only were central transcription factors (TF) STAT3, CEBPB, SPI1, and regulatory mechanisms identified more accurately than with single-omics but also immunotherapy targeting central TFs to drugs was found to be significantly different between patients. Thus, in addition to providing new insights into the potential regulatory mechanisms and pathogenic genes of AD microglia, this approach can assist clinicians in making the most rational treatment plans for patients with different risks; it also has significant implications for identifying AD immunotherapy targets and targeting microglia-associated immune drugs.

Notch3 Transactivates Glycogen Synthase Kinase-3-Beta and Inhibits Epithelial-to-Mesenchymal Transition in Breast Cancer Cells.

As a critical transformational process in the attributes of epithelial cells, epithelial-to-mesenchymal transition (EMT) is involved in tumor invasion, metastasis, and resistance to treatment, which contributes to the ultimate death of some patients with breast cancer. Glycogen synthase kinase-3-beta (GSK3ß) is thought to be an EMT suppressor that down-regulates the protein, snail, a zinc finger transcription inhibitor, and regulates E-cadherin expression and the Wnt signaling pathway. Our previous studies have shown that Notch3 also inhibits EMT in breast cancer. In mammary gland cells, GSK3ß physically bound and phosphorylated the intracellular domain of two Notch paralogs: N1ICD was positively regulated, but N2ICD was negatively regulated; however, the relationship between Notch3, GSK3ß, and EMT in breast cancer is still unclear and crosstalk between Notch3 and GSK3ß has not been widely investigated. In this study, we revealed that Notch3 was an essential antagonist of EMT in breast cancer cells by transcriptionally upregulating GSK3ß. In breast cancer, MCF-7 and MDA-MB-231 cell lines, the silencing of Notch3 reduced GSK3ß expression, which is sufficient to induce EMT. Conversely, ectopic Notch3 expression re-activated GSK3ß and E-cadherin. Mechanistically, Notch3 can bind to the GSK3ß promoter directly and activate GSK3ß transcription. In human breast cancer samples, Notch3 expression is positively associated with GSK3ß (r = 0.416, p = 0.001); moreover, high expressions of Notch3 and GSK3ß mRNA are correlated to better relapse-free survival in all breast cancer patients via analysis in "the Kaplan-Meier plotter" database. In summary, our preliminary results suggested that Notch3 might inhibit EMT by trans-activating GSK3ß in breast cancer cells. The suppression of Notch3 expression may contribute to EMT by transcriptionally downregulating GSK3ß in breast cancer.

Integrative Analysis of the Expression Levels and Prognostic Values for NEK Family Members in Breast Cancer.

Background: In the latest rankings, breast cancer ranks first in incidence and fifth in mortality among female malignancies worldwide. Early diagnosis and treatment can improve the prognosis and prolong the survival of breast cancer (BC) patients. The NIMA-related kinase (NEK), a group of serine/threonine kinase, is a large and conserved gene family that includes NEK1-NEK11. The NEK plays a pivotal role in the cell cycle and microtubule formation. However, an integrative analysis of the effect and prognosis value of NEK family members on BC patients is still lacking. Methods: In this study, the expression profiles of NEK family members in BC and its subgroups were analyzed using UALCAN, GEPIA2, and Human Protein Atlas datasets. The prognostic values of NEK family members in BC were evaluated using the Kaplan-Meier plotter. Co-expression profiles and genetic alterations of NEK family members were analyzed using the cBioPortal database. The function and pathway enrichment analysis of the NEK family were performed using the WebGestalt database. The correlation analysis of the NEK family and immune cell infiltration in BC was conducted using the TIMER 2.0 database. Results: In this study, we compared and analyzed the prognosis values of the NEKs. We found that NEK9 was highly expressed in normal breast tissues than BC, and NEK2, NEK6, and NEK11 were significantly highly expressed in BC than adjacent normal tissues. Interestingly, the expression levels of NEK2, NEK6, and NEK10 were not only remarkably correlated with the tumor stage but also with the molecular subtype. Through multilevel research, we found that high expression levels of NEK1, NEK3, NEK8, NEK9, NEK10, and NEK11 suggested a better prognosis value in BC, while high expression levels of NEK2 and NEK6 suggested a poor prognosis value in BC. Conclusion: Our studies show the prognosis values of the NEKs in BC. Thus, we suggest that NEKs may be regarded as novel biomarkers for predicting potential prognosis values and potential therapeutic targets of BC patients.

Enhancing the oxide-ionic conductivity of Ba3Mo1+xNb1-2xGexO8.5 at intermediate temperatures: the effect of site-selective Ge4+-substitution.

Significant oxide-ionic conductivity has been recently reported for a family of cation-deficient hexagonal perovskite derivatives Ba3M2O8.5 (M = Mo/W6+ and Nb5+/V5+). Herein, strong 4-fold coordination geometry preferring Ge4+ ions are doped into Ba3Mo1+xNb1-2xGexO8.5 to manipulate the oxygen distribution within palmierite-like layers for the enhancement of oxide-ionic conductivity. Rietveld refinement of the neutron diffraction data of Ba3Mo1.2Nb0.6Ge0.2O8.5 reveals that Ge4+-ions are selectively incorporated into the palmierite-like layers, owing to their strong 4-fold coordination environment preference. Such a site-selective doping behavior leads to an increase in the occupation proportion of the O3 site and a concomitant decrease in the occupancy factor for O2. Ionic conduction measurements show that the bulk conductivity of Ba3Mo1.2Nb0.6Ge0.2O8.5 is about twice higher than that of the parent compound at intermediate temperatures (300-500 °C). Furthermore, bond-valence site energy (BVSE) landscape analysis reveals that the oxygen ionic conduction of Ba3Mo1+xNb1-2xGexO8.5 is dominated by the two-dimensional pathways along the palmierite-like layers, despite the three-dimensional (3D) oxygen diffusion pathways being present in the hybrid structure, which strongly confirms that the enhancement in ionic conductivity at intermediate temperatures is attributed to the site-selective Ge4+-substitution-induced redistribution of oxygen ions within the palmierite-like layers.

SCMAG: A Semisupervised Single-Cell Clustering Method Based on Matrix Aggregation Graph Convolutional Neural Network.

Clustering analysis is one of the most important technologies for single-cell data mining. It is widely used in the division of different gene sequences, the identification of functional genes, and the detection of new cell types. Although the traditional unsupervised clustering method does not require label data, the distribution of the original data, the setting of hyperparameters, and other factors all affect the effectiveness of the clustering algorithm. While in some cases the type of some cells is known, it is hoped to achieve high accuracy if the prior information about those cells is utilized sufficiently. In this study, we propose SCMAG (a semisupervised single-cell clustering method based on a matrix aggregation graph convolutional neural network) that takes into full consideration the prior information for single-cell data. To evaluate the performance of the proposed semisupervised clustering method, we test on different single-cell datasets and compare with the current semisupervised clustering algorithm in recognizing cell types on various real scRNA-seq data; the results show that it is a more accurate and significant model.

Corrigendum: TRPC1 Inhibits Cell Proliferation/Invasion and Is Predictive of a Better Prognosis of Esophageal Squamous Cell Carcinoma.

[This corrects the article DOI: 10.3389/fonc.2021.627713.].

Structural Diversity and Incompatibility Induced Complex Phase Formation Behavior in the Stuffed Tridymites Ca1-xSrxGa2O4.

Stuffed tridymites AM2O4 composed of a condensed MO4-tetrahedra-based framework have been widely investigated due to their structural diversity and rich physical properties. Herein, the strategy of stuffing mixed Ca2+ and Sr2+ cations into the [Ga2O4]2- framework in (Ca1-xSrx)Ga2O4 (CSGO, 0 ≤ x ≤ 1) is utilized to manipulate the phase formation behavior with different structure types at particular annealing temperatures. Five derivatives, including α- and ß-CaGa2O4, ß- and γ-SrGa2O4, and new CSGO-type structures, were observed. The distinctive feature of the CSGO-structure is the coexistence of UUDDUD- and UDUDUD-type six-membered rings, where U (up) and D (down) denote the orientations of GaO4-tetrahedra with respect to the plane grids, in a ratio of 2:1. Single-phase α-Ca1-xSrxGa2O4 (x < 0.2) and γ-Ca1-xSrxGa2O4 (x > 0.67) could be obtained at low temperatures. Biphasic regions, including α-Ca1-xSrxGa2O4/CSGO (0.2 ≤ x ≤ 0.67), γ-Ca1-xSrxGa2O4/CSGO (0.67 < x ≤ 0.8), and ß-Ca1-xSrxGa2O4/CSGO (0.8 < x < 1), were observed at the intermediate temperature region and evolve irreversibly into the CSGO single-phase region upon elevating the temperature. Moreover, the structure-property relationship of the new CSGO-phase was further studied by doping coordination-sensitive Bi3+ activators to advance the development and applications of stuffed tridymites.

Mutant p53 and Twist1 Co-Expression Predicts Poor Prognosis and Is an Independent Prognostic Factor in Breast Cancer.

PURPOSE: The basic helix-loop-helix transcription factor (bHLH) transcription factor Twist1 plays a key role in embryonic development and tumorigenesis. p53 is a frequently mutated tumor suppressor in cancer. Both proteins play a key and significant role in breast cancer tumorigenesis. However, the regulatory mechanism and clinical significance of their co-expression in this disease remain unclear. The purpose of this study was to analyze the expression patterns of p53 and Twist1 and determine their association with patient prognosis in breast cancer. We also investigated whether their co-expression could be a potential marker for predicting patient prognosis in this disease. METHODS: Twist1 and mutant p53 expression in 408 breast cancer patient samples were evaluated by immunohistochemistry. Kaplan-Meier Plotter was used to analyze the correlation between co-expression of Twist1 and wild-type or mutant p53 and prognosis for recurrence-free survival (RFS) and overall survival (OS). Univariate analysis, multivariate analysis, and nomograms were used to explore the independent prognostic factors in disease-free survival (DFS) and OS in this cohort. RESULTS: Of the 408 patients enrolled, 237 (58%) had high mutant p53 expression. Two-hundred twenty patients (53.9%) stained positive for Twist1, and 188 cases were Twist1-negative. Furthermore, patients that co-expressed Twist1 and mutant p53 (T+P+) had significantly advanced-stage breast cancer [stage III, 61/89 T+P+ (68.5%) vs. 28/89 T-P- (31.5%); stage II, 63/104 T+P+ (60.6%)vs. 41/104 T-P- (39.4%)]. Co-expression was negatively related to early clinical stage (i.e., stages 0 and I; P = 0.039). T+P+ breast cancer patients also had worse DFS (95% CI = 1.217-7.499, P = 0.017) and OS (95% CI = 1.009-9.272, P = 0.048). Elevated Twist1 and mutant p53 expression predicted shorter RFS in basal-like patients. Univariate and multivariate analysis identified three variables (i.e., lymph node involvement, larger tumor, and T+P+) as independent prognostic factors for DFS. Lymph node involvement and T+P+ were also independent factors for OS in this cohort. The total risk scores and nomograms were reliable for predicting DFS and OS in breast cancer patients. CONCLUSIONS: Our results revealed that co-expression of mutant p53 and Twist1 was associated with advanced clinical stage, triple negative breast cancer (TNBC) subtype, distant metastasis, and shorter DFS and OS in breast cancer patients. Furthermore, lymph nodes status and co-expression of Twist1 and mutant p53 were classified as independent factors for DFS and OS in this cohort. Co-evaluation of mutant p53 and Twist1 might be an appropriate tool for predicting breast cancer patient outcome.

Notch3 inhibits cell proliferation and tumorigenesis and predicts better prognosis in breast cancer through transactivating PTEN.

Notch receptors (Notch1-4) play critical roles in tumorigenesis and metastasis of malignant tumors, including breast cancer. Although abnormal Notch activation is related to various tumors, the importance of single receptors and their mechanism of activation in distinct breast cancer subtypes are still unclear. Previous studies by our group demonstrated that Notch3 may inhibit the emergence and progression of breast cancer. PTEN is a potent tumor suppressor, and its loss of function is sufficient to promote the occurrence and progression of tumors. Intriguingly, numerous studies have revealed that Notch1 is involved in the regulation of PTEN through its binding to CBF-1, a Notch transcription factor, and the PTEN promoter. In this study, we found that Notch3 and PTEN levels correlated with the luminal phenotype in breast cancer cell lines. Furthermore, we demonstrated that Notch3 transactivated PTEN by binding CSL-binding elements in the PTEN promoter and, at least in part, inhibiting the PTEN downstream AKT-mTOR pathway. Notably, Notch3 knockdown downregulated PTEN and promoted cell proliferation and tumorigenesis. In contrast, overexpression of the Notch3 intracellular domain upregulated PTEN and inhibited cell proliferation and tumorigenesis in vitro and in vivo. Moreover, inhibition or overexpression of PTEN partially reversed the promotion or inhibition of cell proliferation induced by Notch3 alterations. In general, Notch3 expression positively correlated with elevated expression of PTEN, ER, lower Ki-67 index, and incidence of involved node status and predicted better recurrence-free survival in breast cancer patients. Therefore, our findings demonstrate that Notch3 inhibits breast cancer proliferation and suppresses tumorigenesis by transactivating PTEN expression.

TRPC1 Inhibits Cell Proliferation/Invasion and Is Predictive of a Better Prognosis of Esophageal Squamous Cell Carcinoma.

BACKGROUND AND OBJECTIVES: In China, over 90% of esophageal cancer (EC) cases are esophageal squamous cell carcinoma (ESCC). ESCC is a frequently malignant tumor with poor prognosis despite the development of comprehensive therapeutic strategies, for which there is still a lack of effective prognostic factors. Previous studies found that the abnormal expression of TRPC1 is closely related to the proliferation, invasion, metastasis, and differentiation of various tumors. However, the relationship between TRPC1 and ESCC is currently unclear. The present study aimed to clarify the clinical significance of TRPC1 and to preliminarily assess the molecular mechanism by which TRPC1 regulates cell proliferation, migration, and invasion in ESCC. MATERIALS AND METHODS: Immunohistochemistry (IHC) was used to determine the expression of TRPC1 and Ki-67 in 165 cases of ESCC. The correlations between TRPC1 expression and clinicopathological characteristics were determined, and both univariate and multivariate analyses were utilized to quantify the impact of TRPC1 expression on patient survival. Cell Counting Kit-8, scratch wound healing, and transwell assays were used to determine the effects of TRPC1 on proliferation, migration, and invasion in ESCC in vitro, respectively. RESULTS: The positive expression rate of TRPC1 showed significantly decreased in ESCC (45.50%) compared with the levels in normal esophageal mucosa (NEM; 80.80%) and high-grade intraepithelial neoplasia (HGIEN; 63.20%) (P<0.001). Higher expression rate of TRPC1 was associated with low lymph node metastasis (P<0.001), high differentiation (rs = 0.232, P=0.003), and low Ki-67 (rs = -0.492, P<0.001). We further revealed that low expression of TRPC1 was associated with poor prognosis (Disease-free survival, DFS: 95% CI=0.545-0.845, P=0.001; Overall survival, OS: 95% CI=0.553-0.891, P=0.004). Furthermore, we showed that downregulation of TRPC1 promoted the proliferation, migration, and invasion of human esophageal squamous cell carcinoma cell line EC9706 in vitro. In contrast, overexpression of TRPC1 inhibited the proliferation, migration, and invasion of human esophageal squamous cell carcinoma cell line KYSE150 (P<0.01), in a manner at least in part mediated through the AKT/p27 pathway. CONCLUSION: TRPC1 inhibited the proliferation, migration, and invasion of EC9706 and KYSE150 cells, at least, in part mediated through the AKT/p27 pathway in vitro. The downregulation of TRPC1 may be one of the most important molecular events in the malignant progression of ESCC. TRPC1 could be a new candidate tumor suppressor gene and a new prognostic factor of ESCC.

Complex crystal structure and photoluminescence of Bi3+-doped and Bi3+/Eu3+ co-doped Ca7Mg2Ga6O18.

Recently, broad-band white-light-emitting using Eu2+, Ce3+, or Bi3+ in multi-sites of a single-phase phosphor have drawn extensive attention due to their potential to realize high-quality indoor lighting. This work reports a novel oxide, Ca7Mg2Ga6O18 (CMG), possessing a complex crystal structure in the space group F432. Rietveld refinements of high-resolution synchrotron X-ray diffraction data were performed to determine the accurate atomic positions and occupancy factors, giving a reasonable composition of Ca7Mg1.91(4)Ga6.09(4)O18. Due to the multiple sites of Ca2+, which are suitable for the doping of Bi3+ activators, CMG is a promising host to achieve broad-band white-light emission. Detailed structural and spectroscopic analyses revealed that the Bi3+-activator shows multiple and site-selective occupancy, which is the origin of the red-shifts in both broad-band excitation and emission spectra upon increasing the Bi3+ content. A series of Bi3+ and Eu3+ codoped phosphors with tunable blue-pink-red emission were prepared due to the Bi3+-to-Eu3+ energy transfer. Due to the distinctive thermal behaviors of Bi3+ and Eu3+ emissions, CMG:Bi3+,Eu3+ is a candidate for optical thermometry.

The lncRNA SLCO4A1-AS1/miR-876-3p/RBBP6 axis regulates cell proliferation and apoptosis in acute lymphocytic leukemia via the JNK signaling pathway.

INTRODUCTION: Acute lymphocytic leukemia (ALL) is a hematologic malignancy caused by the clonal proliferation of immature lymphocytes. Long noncoding RNAs (lncRNAs) have been reported as critical regulators in several cancers, including ALL. LncRNA SLCO4A1 antisense RNA 1 (SLCO4A1-AS1) has been revealed to be implicated in tumorigenesis of several cancers. Our study focused on the role of SLCO4A1-AS1 in ALL. METHODS: RT-qPCR, Western blot analysis, CCK-8, EdU, and Flow cytometry analysis were used to explore the biological function of SLCO4A1-AS1 in ALL cellular processes. Luciferase reporter and RNA pull-down assays were applied to explore the mechanism of SLCO4A1-AS1 in ALL cells. RESULTS: SLCO4A1-AS1 was upregulated in ALL tissues and cell lines. We found that suppression of SLCO4A1-AS1 suppressed ALL cell proliferation and facilitated cell apoptosis. Our result confirmed that SLCO4A1-AS1 acted as a ceRNA by sponging microRNA 876-3p (miR-876-3p) to upregulate retinoblastoma binding protein 6 (RBBP6) expression in ALL cells. Moreover, SLCO4A1-AS1 activated the JNK signaling pathway by upregulating RBBP6. Rescue assays revealed that the activation of the JNK signaling or overexpression of RBBP6 revered the suppressive effect of SLCO4A1-AS1 knockdown on growth of ALL cells. CONCLUSION: SLCO4A1-AS1 promoted cell growth of ALL by the miR-876-3p/RBBP6 axis to activate the JNK signaling pathway.

Rationalize the Significantly Enhanced Photocatalytic Efficiency of In3+-doped α'-Ga2S3 by Bond Theory and Local Structural Distortion.

Mechanistic understanding on the electronic structure of α'-Ga2S3 unravel that the electrons in nonbonding 3pz orbitals of two-coordinated S2- anions are photoexcited to the adjacent σ-type antibonding orbitals (Ga-4s and S-3p) and migrate thereafter to the surface along the a-axis. By introduction of the In-S antibonding on the one hand and modifying the local dipole moment on the other hand, the light absorption ability and charge separation efficiency can be both enhanced by In3+-to-Ga3+ substitution, and the photocatalytic H2 evolution rate can be significantly promoted. Local geometric distortion is common in solid solutions, but its effect on charge migration behavior has yet been considered in semiconducting photocatalysis. Our case study on In3+-doped Ga2S3 is a good reminder of such the importance.

Ambient pressure synthesis of Eu3+ doped δ-BiB3O6 by seed-assisted high temperature solid state reactions.

δ-BiB3O6 shows a comparable nonlinear optical performance with the famous α-BiB3O6. It can be prepared either by a high temperature-high pressure method or by a sol-gel method associated with RE3+-doping (RE = La, Ce, Pr, and Nd). A direct solid state reaction at 700 °C stabilized 20 atom% La3+ doped δ-BiB3O6 compared to the previously reported record (15 atom%) in the literature. La3+ doping would not only expand the thermodynamically stable region, which is critical for the synthesis, but also hasten the crystallization process. Moreover, Eu3+, a smaller RE cation, was also doped for the first time at a high doping level (7 atom%) simply by a seed-assisted solid state reaction, which apparently provides additional functionality and will prompt further efforts on single crystal growth of RE3+-doped δ-BiB3O6 under ambient pressure. The combined powder X-ray diffraction and transmission electron microscopy analysis underpinned the phase purity and doping homogeneity of cation doped bismuth borates. UV-excited red luminescence was observed for δ-Bi0.93Eu0.07B3O6.

Chemical-substitution-induced successive symmetry descent and structure-property correlation for "114" oxides CaBa1-xSrxZn2Al2O7.

The crystal structures, photoluminescence properties, and transport properties of a series of new "114" oxides CaBa1-xSrxZn2Al2O7 (x = 0-1) were investigated in detail. Careful Rietveld refinements performed on solid solution samples revealed that the structural symmetry of CaBa1-xSrxZn2Al2O7 evolves from hexagonal P63mc (x < 0.2) to trigonal P31c (0.2 ≤ x ≤ 0.6) and then to orthorhombic Pna21 (x > 0.6) with an increase of the Sr2+-content, which is cooperative with the rotation of T1O4 tetrahedra around the c-axis. Eu3+ was used as a local structural probe to gain an insight into the structure, which further corroborated the correctness of the observed structural symmetry descending sequence in CaBa1-xSrxZn2Al2O7. More importantly, the reduction of structural symmetry is also associated with a tendency from layered ordering to complete charge ordering transition for Zn2+/Al3+ cations, which was revealed to have a significant influence on the transport properties. These findings are expected to offer a route to manipulate the physical properties of "114" oxides containing magnetic cations.